A role of peripheral myelin protein 2 in lipid homeostasis of myelinating schwann cells

  • Jennifer Zenker
    Department of Medical Genetics University of Lausanne Switzerland
  • Mark Stettner
    Department of Neurology, Medical Faculty Research Group for Clinical and Experimental Neuroimmunology, Heinrich‐Heine‐University Düsseldorf Germany
  • Salla Ruskamo
    Faculty of Biochemistry and Molecular Medicine and Biocenter Oulu University of Oulu Oulu Finland
  • Enric Domènech‐Estévez
    Department of Medical Genetics University of Lausanne Switzerland
  • Hasna Baloui
    Department of Medical Genetics University of Lausanne Switzerland
  • Jean‐Jacques Médard
    Department of Medical Genetics University of Lausanne Switzerland
  • Mark H. G. Verheijen
    Department of Molecular and Cellular Neurobiology Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University The Netherlands
  • Jos F. Brouwers
    Department of Biochemistry and Cell Biology Faculty of Veterinary Medicine, Utrecht University 3508 TC Utrecht The Netherlands
  • Petri Kursula
    Faculty of Biochemistry and Molecular Medicine and Biocenter Oulu University of Oulu Oulu Finland
  • Bernd C. Kieseier
    Department of Neurology, Medical Faculty Research Group for Clinical and Experimental Neuroimmunology, Heinrich‐Heine‐University Düsseldorf Germany
  • Roman Chrast
    Department of Medical Genetics University of Lausanne Switzerland

書誌事項

公開日
2014-05-21
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/glia.22696
公開者
Wiley

この論文をさがす

説明

<jats:p>Peripheral myelin protein 2 (Pmp2, P2 or Fabp8), a member of the fatty acid binding protein family, was originally described together with myelin basic protein (Mbp or P1) and myelin protein zero (Mpz or P0) as one of the most abundant myelin proteins in the peripheral nervous system (PNS). Although Pmp2 is predominantly expressed in myelinated Schwann cells, its role in glia is currently unknown. To study its function in PNS biology, we have generated a complete Pmp2 knockout mouse (<jats:italic>Pmp2<jats:sup>‐/‐</jats:sup></jats:italic>). Comprehensive characterization of <jats:italic>Pmp2<jats:sup>‐/‐</jats:sup></jats:italic> mice revealed a temporary reduction in their motor nerve conduction velocity (MNCV). While this change was not accompanied by any defects in general myelin structure, we detected transitory alterations in the myelin lipid profile of <jats:italic>Pmp2<jats:sup>‐/‐</jats:sup></jats:italic> mice. It was previously proposed that Pmp2 and Mbp have comparable functions in the PNS suggesting that the presence of Mbp can partially mask the <jats:italic>Pmp2<jats:sup>‐/‐</jats:sup></jats:italic> phenotype. Indeed, we found that Mbp lacking <jats:italic>Shi<jats:sup>‐/‐</jats:sup></jats:italic> mice, similar to <jats:italic>Pmp2<jats:sup>‐/‐</jats:sup></jats:italic> animals, have preserved myelin structure and reduced MNCV, but this phenotype was not aggravated in <jats:italic>Pmp2<jats:sup>‐/‐</jats:sup></jats:italic>/<jats:italic>Shi<jats:sup>‐/‐</jats:sup></jats:italic> mutants indicating that Pmp2 and Mbp do not substitute each other's functions in the PNS. These data, together with our observation that Pmp2 binds and transports fatty acids to membranes, uncover a role for Pmp2 in lipid homeostasis of myelinating Schwann cells. GLIA 2014;62:1502–1512</jats:p>

収録刊行物

  • Glia

    Glia 62 (9), 1502-1512, 2014-05-21

    Wiley

被引用文献 (3)*注記

もっと見る

問題の指摘

ページトップへ